Financiere Des Professionnels Fonds D,Investissement Inc. Krystal Biotech, Inc. Transaction History
Financiere Des Professionnels Fonds D,Investissement Inc.
- $1.66 Trillion
- Q2 2025
A detailed history of Financiere Des Professionnels Fonds D,Investissement Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Financiere Des Professionnels Fonds D,Investissement Inc. holds 1,182 shares of KRYS stock, worth $213,433. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,182Holding current value
$213,433% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
312Shares Held
24.7MCall Options Held
417KPut Options Held
485K-
Black Rock Inc. New York, NY3.95MShares$713 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$510 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$480 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$245 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$170 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.63B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...